Quality of Life in Patients Treated With Leadless Pacemakers
NCT ID: NCT05958836
Last Updated: 2023-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
246 participants
OBSERVATIONAL
2023-07-31
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Leadless Pacemakers Versus Left Bundle Area Pacing - A Preliminary Exploration
NCT06690333
Factors Affecting Selection of Leadless Pacemaker and Atrioventricular Synchronous Pacing Status
NCT06587672
LIFE Study - Limiting Chronotropic Incompetence for Pacemaker Recipients
NCT00146861
Key Factors of Leadless Pacemaker Implantation With Implantation Site, Complications and Prognosis
NCT05761821
Patient Preferences for Leadless Pacemakers
NCT05327101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Micra TPS group
pacemaker
Micra TPS or traditional PM group
Traditional PM group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pacemaker
Micra TPS or traditional PM group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Conforming to indication of a pacemaker implantation;
* Life expectancy\>1 year;
* Normal cardiac function with preserved LVEF;
* Adequate self-care ability or self-help skills before pacemaker implantation;
* Mentally healthy so as to participate in the quality-of-life assessments;
* Willing to participate in study through consent and willing to undergo study specific required procedures with expectancy of geographically stable for follow up duration.
Exclusion Criteria
* Subject with persistent symptomatic sinus bradycardia;
* Subject has an existing or prior pacemaker, ICD or CRT device implant;
* Subject has unstable angina pectoris or has an acute myocardial infarction (AMI) in the 30 days prior to eligibility assessment;
* Subjects with a mechanical tricuspid valve, implanted vena cava filter, or left ventricular assist device (LVAD);
* Subjects with a life expectancy of less than 12-months;
* Subjects with medical condition which precludes patient from participation in the opinion of the investigator, such as arthritis, lung disease or previous stroke, renal dysfunction, recent major surgery within six months, clinically overt congestive heart failure;
* Pregnant women or breastfeeding women, or women of child bearing potential and who are not on a reliable form of birth regulation method or abstinence;
* Psychological disorders unable to participate in the quality-of-life assessments.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MicraQL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.